sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Neurodegenerative Disease Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Neurodegenerative Disease Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Category : Pharmaceuticals and Healthcare QY Research Pages :92
Published Date : 2020-12-15

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Neurodegenerative Disease Market with our analysts monitoring the situation across the globe.
Neurodegenerative Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neurodegenerative Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The key players covered in this study Novartis Pfizer Merck Serono Biogen Idec TEVA UCB Boehringer Ingelheim Sanofi GlaxoSmithKline Market segment by Type, the product can be split into NMDA SSRIs Dopamine Inhibitors Market segment by Application, split into Parkinson’s Disease Huntington Disease Amyotrophic Lateral Sclerosis Alzheimer’s Disease Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Neurodegenerative Disease Revenue 1.4 Market by Type 1.4.1 Global Neurodegenerative Disease Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 NMDA 1.4.3 SSRIs 1.4.4 Dopamine Inhibitors 1.5 Market by Application 1.5.1 Global Neurodegenerative Disease Market Share by Application: 2020 VS 2026 1.5.2 Parkinson’s Disease 1.5.3 Huntington Disease 1.5.4 Amyotrophic Lateral Sclerosis 1.5.5 Alzheimer’s Disease 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Global Neurodegenerative Disease Market Perspective (2015-2026) 2.2 Global Neurodegenerative Disease Growth Trends by Regions 2.2.1 Neurodegenerative Disease Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Neurodegenerative Disease Historic Market Share by Regions (2015-2020) 2.2.3 Neurodegenerative Disease Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Neurodegenerative Disease Market Growth Strategy 2.3.6 Primary Interviews with Key Neurodegenerative Disease Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Neurodegenerative Disease Players by Market Size 3.1.1 Global Top Neurodegenerative Disease Players by Revenue (2015-2020) 3.1.2 Global Neurodegenerative Disease Revenue Market Share by Players (2015-2020) 3.1.3 Global Neurodegenerative Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Neurodegenerative Disease Market Concentration Ratio 3.2.1 Global Neurodegenerative Disease Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Neurodegenerative Disease Revenue in 2019 3.3 Neurodegenerative Disease Key Players Head office and Area Served 3.4 Key Players Neurodegenerative Disease Product Solution and Service 3.5 Date of Enter into Neurodegenerative Disease Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Neurodegenerative Disease Historic Market Size by Type (2015-2020) 4.2 Global Neurodegenerative Disease Forecasted Market Size by Type (2021-2026) 5 Market Size by Application (2015-2026) 5.1 Global Neurodegenerative Disease Market Size by Application (2015-2020) 5.2 Global Neurodegenerative Disease Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Neurodegenerative Disease Market Size (2015-2020) 6.2 Neurodegenerative Disease Key Players in North America (2019-2020) 6.3 North America Neurodegenerative Disease Market Size by Type (2015-2020) 6.4 North America Neurodegenerative Disease Market Size by Application (2015-2020) 7 Europe 7.1 Europe Neurodegenerative Disease Market Size (2015-2020) 7.2 Neurodegenerative Disease Key Players in Europe (2019-2020) 7.3 Europe Neurodegenerative Disease Market Size by Type (2015-2020) 7.4 Europe Neurodegenerative Disease Market Size by Application (2015-2020) 8 China 8.1 China Neurodegenerative Disease Market Size (2015-2020) 8.2 Neurodegenerative Disease Key Players in China (2019-2020) 8.3 China Neurodegenerative Disease Market Size by Type (2015-2020) 8.4 China Neurodegenerative Disease Market Size by Application (2015-2020) 9 Japan 9.1 Japan Neurodegenerative Disease Market Size (2015-2020) 9.2 Neurodegenerative Disease Key Players in Japan (2019-2020) 9.3 Japan Neurodegenerative Disease Market Size by Type (2015-2020) 9.4 Japan Neurodegenerative Disease Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Neurodegenerative Disease Market Size (2015-2020) 10.2 Neurodegenerative Disease Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Neurodegenerative Disease Market Size by Type (2015-2020) 10.4 Southeast Asia Neurodegenerative Disease Market Size by Application (2015-2020) 11 India 11.1 India Neurodegenerative Disease Market Size (2015-2020) 11.2 Neurodegenerative Disease Key Players in India (2019-2020) 11.3 India Neurodegenerative Disease Market Size by Type (2015-2020) 11.4 India Neurodegenerative Disease Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Neurodegenerative Disease Market Size (2015-2020) 12.2 Neurodegenerative Disease Key Players in Central & South America (2019-2020) 12.3 Central & South America Neurodegenerative Disease Market Size by Type (2015-2020) 12.4 Central & South America Neurodegenerative Disease Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Novartis 13.1.1 Novartis Company Details 13.1.2 Novartis Business Overview 13.1.3 Novartis Neurodegenerative Disease Introduction 13.1.4 Novartis Revenue in Neurodegenerative Disease Business (2015-2020)) 13.1.5 Novartis Recent Development 13.2 Pfizer 13.2.1 Pfizer Company Details 13.2.2 Pfizer Business Overview 13.2.3 Pfizer Neurodegenerative Disease Introduction 13.2.4 Pfizer Revenue in Neurodegenerative Disease Business (2015-2020) 13.2.5 Pfizer Recent Development 13.3 Merck Serono 13.3.1 Merck Serono Company Details 13.3.2 Merck Serono Business Overview 13.3.3 Merck Serono Neurodegenerative Disease Introduction 13.3.4 Merck Serono Revenue in Neurodegenerative Disease Business (2015-2020) 13.3.5 Merck Serono Recent Development 13.4 Biogen Idec 13.4.1 Biogen Idec Company Details 13.4.2 Biogen Idec Business Overview 13.4.3 Biogen Idec Neurodegenerative Disease Introduction 13.4.4 Biogen Idec Revenue in Neurodegenerative Disease Business (2015-2020) 13.4.5 Biogen Idec Recent Development 13.5 TEVA 13.5.1 TEVA Company Details 13.5.2 TEVA Business Overview 13.5.3 TEVA Neurodegenerative Disease Introduction 13.5.4 TEVA Revenue in Neurodegenerative Disease Business (2015-2020) 13.5.5 TEVA Recent Development 13.6 UCB 13.6.1 UCB Company Details 13.6.2 UCB Business Overview 13.6.3 UCB Neurodegenerative Disease Introduction 13.6.4 UCB Revenue in Neurodegenerative Disease Business (2015-2020) 13.6.5 UCB Recent Development 13.7 Boehringer Ingelheim 13.7.1 Boehringer Ingelheim Company Details 13.7.2 Boehringer Ingelheim Business Overview 13.7.3 Boehringer Ingelheim Neurodegenerative Disease Introduction 13.7.4 Boehringer Ingelheim Revenue in Neurodegenerative Disease Business (2015-2020) 13.7.5 Boehringer Ingelheim Recent Development 13.8 Sanofi 13.8.1 Sanofi Company Details 13.8.2 Sanofi Business Overview 13.8.3 Sanofi Neurodegenerative Disease Introduction 13.8.4 Sanofi Revenue in Neurodegenerative Disease Business (2015-2020) 13.8.5 Sanofi Recent Development 13.9 GlaxoSmithKline 13.9.1 GlaxoSmithKline Company Details 13.9.2 GlaxoSmithKline Business Overview 13.9.3 GlaxoSmithKline Neurodegenerative Disease Introduction 13.9.4 GlaxoSmithKline Revenue in Neurodegenerative Disease Business (2015-2020) 13.9.5 GlaxoSmithKline Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

Get Free Sample

List of Tables Table 1. Neurodegenerative Disease Key Market Segments Table 2. Key Players Covered: Ranking by Neurodegenerative Disease Revenue Table 3. Ranking of Global Top Neurodegenerative Disease Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Neurodegenerative Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of NMDA Table 6. Key Players of SSRIs Table 7. Key Players of Dopamine Inhibitors Table 8. Global Neurodegenerative Disease Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Neurodegenerative Disease Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Neurodegenerative Disease Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Neurodegenerative Disease Market Share by Regions (2015-2020) Table 12. Global Neurodegenerative Disease Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Neurodegenerative Disease Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Neurodegenerative Disease Market Growth Strategy Table 18. Main Points Interviewed from Key Neurodegenerative Disease Players Table 19. Global Neurodegenerative Disease Revenue by Players (2015-2020) (Million US$) Table 20. Global Neurodegenerative Disease Market Share by Players (2015-2020) Table 21. Global Top Neurodegenerative Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurodegenerative Disease as of 2019) Table 22. Global Neurodegenerative Disease by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Neurodegenerative Disease Product Solution and Service Table 25. Date of Enter into Neurodegenerative Disease Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Neurodegenerative Disease Market Size by Type (2015-2020) (Million US$) Table 28. Global Neurodegenerative Disease Market Size Share by Type (2015-2020) Table 29. Global Neurodegenerative Disease Revenue Market Share by Type (2021-2026) Table 30. Global Neurodegenerative Disease Market Size Share by Application (2015-2020) Table 31. Global Neurodegenerative Disease Market Size by Application (2015-2020) (Million US$) Table 32. Global Neurodegenerative Disease Market Size Share by Application (2021-2026) Table 33. North America Key Players Neurodegenerative Disease Revenue (2019-2020) (Million US$) Table 34. North America Key Players Neurodegenerative Disease Market Share (2019-2020) Table 35. North America Neurodegenerative Disease Market Size by Type (2015-2020) (Million US$) Table 36. North America Neurodegenerative Disease Market Share by Type (2015-2020) Table 37. North America Neurodegenerative Disease Market Size by Application (2015-2020) (Million US$) Table 38. North America Neurodegenerative Disease Market Share by Application (2015-2020) Table 39. Europe Key Players Neurodegenerative Disease Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Neurodegenerative Disease Market Share (2019-2020) Table 41. Europe Neurodegenerative Disease Market Size by Type (2015-2020) (Million US$) Table 42. Europe Neurodegenerative Disease Market Share by Type (2015-2020) Table 43. Europe Neurodegenerative Disease Market Size by Application (2015-2020) (Million US$) Table 44. Europe Neurodegenerative Disease Market Share by Application (2015-2020) Table 45. China Key Players Neurodegenerative Disease Revenue (2019-2020) (Million US$) Table 46. China Key Players Neurodegenerative Disease Market Share (2019-2020) Table 47. China Neurodegenerative Disease Market Size by Type (2015-2020) (Million US$) Table 48. China Neurodegenerative Disease Market Share by Type (2015-2020) Table 49. China Neurodegenerative Disease Market Size by Application (2015-2020) (Million US$) Table 50. China Neurodegenerative Disease Market Share by Application (2015-2020) Table 51. Japan Key Players Neurodegenerative Disease Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Neurodegenerative Disease Market Share (2019-2020) Table 53. Japan Neurodegenerative Disease Market Size by Type (2015-2020) (Million US$) Table 54. Japan Neurodegenerative Disease Market Share by Type (2015-2020) Table 55. Japan Neurodegenerative Disease Market Size by Application (2015-2020) (Million US$) Table 56. Japan Neurodegenerative Disease Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Neurodegenerative Disease Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Neurodegenerative Disease Market Share (2019-2020) Table 59. Southeast Asia Neurodegenerative Disease Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Neurodegenerative Disease Market Share by Type (2015-2020) Table 61. Southeast Asia Neurodegenerative Disease Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Neurodegenerative Disease Market Share by Application (2015-2020) Table 63. India Key Players Neurodegenerative Disease Revenue (2019-2020) (Million US$) Table 64. India Key Players Neurodegenerative Disease Market Share (2019-2020) Table 65. India Neurodegenerative Disease Market Size by Type (2015-2020) (Million US$) Table 66. India Neurodegenerative Disease Market Share by Type (2015-2020) Table 67. India Neurodegenerative Disease Market Size by Application (2015-2020) (Million US$) Table 68. India Neurodegenerative Disease Market Share by Application (2015-2020) Table 69. Central & South America Key Players Neurodegenerative Disease Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Neurodegenerative Disease Market Share (2019-2020) Table 71. Central & South America Neurodegenerative Disease Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Neurodegenerative Disease Market Share by Type (2015-2020) Table 73. Central & South America Neurodegenerative Disease Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Neurodegenerative Disease Market Share by Application (2015-2020) Table 75. Novartis Company Details Table 76. Novartis Business Overview Table 77. Novartis Product Table 78. Novartis Revenue in Neurodegenerative Disease Business (2015-2020) (Million US$) Table 79. Novartis Recent Development Table 80. Pfizer Company Details Table 81. Pfizer Business Overview Table 82. Pfizer Product Table 83. Pfizer Revenue in Neurodegenerative Disease Business (2015-2020) (Million US$) Table 84. Pfizer Recent Development Table 85. Merck Serono Company Details Table 86. Merck Serono Business Overview Table 87. Merck Serono Product Table 88. Merck Serono Revenue in Neurodegenerative Disease Business (2015-2020) (Million US$) Table 89. Merck Serono Recent Development Table 90. Biogen Idec Company Details Table 91. Biogen Idec Business Overview Table 92. Biogen Idec Product Table 93. Biogen Idec Revenue in Neurodegenerative Disease Business (2015-2020) (Million US$) Table 94. Biogen Idec Recent Development Table 95. TEVA Company Details Table 96. TEVA Business Overview Table 97. TEVA Product Table 98. TEVA Revenue in Neurodegenerative Disease Business (2015-2020) (Million US$) Table 99. TEVA Recent Development Table 100. UCB Company Details Table 101. UCB Business Overview Table 102. UCB Product Table 103. UCB Revenue in Neurodegenerative Disease Business (2015-2020) (Million US$) Table 104. UCB Recent Development Table 105. Boehringer Ingelheim Company Details Table 106. Boehringer Ingelheim Business Overview Table 107. Boehringer Ingelheim Product Table 108. Boehringer Ingelheim Revenue in Neurodegenerative Disease Business (2015-2020) (Million US$) Table 109. Boehringer Ingelheim Recent Development Table 110. Sanofi Business Overview Table 111. Sanofi Product Table 112. Sanofi Company Details Table 113. Sanofi Revenue in Neurodegenerative Disease Business (2015-2020) (Million US$) Table 114. Sanofi Recent Development Table 115. GlaxoSmithKline Company Details Table 116. GlaxoSmithKline Business Overview Table 117. GlaxoSmithKline Product Table 118. GlaxoSmithKline Revenue in Neurodegenerative Disease Business (2015-2020) (Million US$) Table 119. GlaxoSmithKline Recent Development Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Global Neurodegenerative Disease Market Share by Type: 2020 VS 2026 Figure 2. NMDA Features Figure 3. SSRIs Features Figure 4. Dopamine Inhibitors Features Figure 5. Global Neurodegenerative Disease Market Share by Application: 2020 VS 2026 Figure 6. Parkinson’s Disease Case Studies Figure 7. Huntington Disease Case Studies Figure 8. Amyotrophic Lateral Sclerosis Case Studies Figure 9. Alzheimer’s Disease Case Studies Figure 10. Neurodegenerative Disease Report Years Considered Figure 11. Global Neurodegenerative Disease Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Neurodegenerative Disease Market Share by Regions: 2020 VS 2026 Figure 13. Global Neurodegenerative Disease Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Neurodegenerative Disease Market Share by Players in 2019 Figure 16. Global Top Neurodegenerative Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurodegenerative Disease as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Neurodegenerative Disease Revenue in 2019 Figure 18. North America Neurodegenerative Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Neurodegenerative Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Neurodegenerative Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Neurodegenerative Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Neurodegenerative Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Neurodegenerative Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Neurodegenerative Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Bottom-up and Top-down Approaches for This Report Figure 26. Data Triangulation Figure 27. Key Executives Interviewed

Get Free Sample

Related Reports

Global Neurodegenerative Disease Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Neurodegenerative Disease Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Neurodegenerative Disease Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Neurodegenerative Disease Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Neurodegenerative Disease Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)